-
10m 9sPart 2 | Session 5 Real-World EVOQUE Outcomes from TVT Registry
-
8m 6sPart 2 | Session 6 PASCAL Precision System in Complex Degenerative MR
-
7m 2sPart 2 | Session 7 PREVUE-VALVE: Prevalence of Valvular Heart Disease in Older Americans
-
7m 4s
-
6m 55sPart 2 | Session 9 Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
-
4m 10sPart 2 | Session 10 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
-
28m 2sPart 2 | Session 11 1-Year ENCIRCLE TMVR Results with SAPIEN M3
-
10m 32s
-
14m 58s
-
6m 49sPart 1 | Session 1 5 Trials That Will Change My Practice with Dr Mirvat Alasnag
-
2m 12sPart 1 | Session 2 2 Trials That Will Change My Practice with Prof Rasha Al-Lamee
-
3m 51sPart 1 | Session 3 3 Ways AI Will Change Your Practice
-
21m 50sPart 1 | Session 4 TCT 25 Structural Interventions Highlights
-
5m 33sPart 2 | Session 1 SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
-
5m 49s
TCT 2025 - Dr Nadira Hamid (Allina Health Minneapolis Heart Institute, Minneapolis, US) is joined by Dr Jonathan Schwartz (Sanger Heart and Vascular Institute, Charlotte, US) to discuss the lessons learned from the update of the TRILUMINATE Pivotal Trial (NCT03904147), investigating tricuspid TEER (transcatheter edge-to-edge repair) in 800+ patients with severe tricuspid regurgitation.
Findings at 30 days showed that TriClip was both safe and effective, with improvements in quality of life. Low rates of mortality, heart failure hospitalisations, bleeding, conduction disturbances and device mortality were observed.
Recorded on-site at TCT Conference in San Francisco, 2025.
Editor: Yazmin Sadik
Video Specialist: Tom Green, Mike Knight
Support: This is an independent interview produced by Transcatheter Academy.
Stay Updated with Our TCT 2025 Video Coverage
We’re bringing you independent, critical insights straight from TCT 2025.
Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.
Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.
Hear Dr Mirvat Alasnag and Dr Rasha Al-Lamee share their views on the data they believe will have the greatest impact on clinical practice.
Follow the hot topics driving innovation in interventional cardiology, and stay tuned for fresh perspectives, real-world insights and global viewpoints, all coming soon on Transcatheter Academy.
More from this programme
Part 1
Highlights
Part 2
Expert Interviews
Part 3
NVM Cardiology Conference Perspectives
A focused video series where Prof Nicolas Van Mieghem offers expert reflections on the most impactful late-breaking trials shaping interventional cardiology at TCT 2025.
Faculty Biographies
Nadira Hamid
Cardiologist & Director of the Echocardiography Core Laboratory
Dr Nadira Hamid is a non-invasive cardiologist specialising in advanced echocardiography and structural heart disease. She is Director of the Echocardiography Core Laboratory at the Minneapolis Heart Institute Foundation in Minneapolis, Minnesota, where she supports structural heart and valvular disease programmes through multimodality cardiac imaging.
Her clinical practice focuses on echocardiography-guided assessment and imaging support for transcatheter structural heart interventions, including aortic, mitral, and tricuspid valve procedures.
Current Roles and Responsibilities
Since January 2024, Dr Hamid has served as Director of the Echocardiography Core Laboratory at the Minneapolis Heart Institute Foundation. In this role, she oversees echocardiography imaging protocols, quality assurance, and clinical imaging support for structural heart disease and valvular heart disease programmes.
She works within a multidisciplinary heart team, integrating…
Jonathan Schwartz
Structural Interventionalist
Dr Jonathan Schwartz is a Structural Interventionalist at Sanger Heart and Vascular Institute in Charlotte, US.
Comments